SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories informs about analyst meet

27 Jan 2026 Evaluate
Neuland Laboratories has informed that the company will announce its results for the third quarter and nine months ended December 31, 2025 on February 09, 2026. The results will also be made available on the website of the Company, www.neulandlabs.com. The management of the Company will host an Earnings Call on February 09, 2026 at 17:30 hrs. 

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

17166.70 206.75 (1.22%)
09-Jun-2026 14:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1774.90
Dr. Reddys Lab 1265.15
Cipla 1378.40
Zydus Lifesciences 1101.75
Lupin 2264.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×